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Introduction 
 
 
Proteinuria, the loss of proteins in urine, is a key marker of dysfunction in kidney 
glomerulus. The degree of proteinuria in patients with renal disease correlates 
closely with the severity of damage to the glomerulus. However, despite the 
pathophysiological relevance of this marker, the exact mechanisms of glomerular 
damage resulting in overt proteinuria remain poorly understood.  
 
Glomerular filtration barrier is composed of three separate layers: endothelium, 
glomerular basement membrane (GBM) and glomerular epithelial cells, podo-
cytes. Along with the recent molecular findings, podocytes are emerging as a key 
cell type involved in glomerular filtration barrier. The ability of podocytes to form 
foot processes with unique intercellular slit diaphragms (SD) reflects a special or-
ganization involved in glomerular filtration. The protein complex forming the SD 
has been basically unknown until the cloning of human NPHS1, the gene encod-
ing nephrin protein. Mutations in NPHS1 cause congenital nephrotic syndrome of 
the Finnish type (CNF), manifesting e.g. as massive proteinuria and the lack of 
SD. 
 
The purpose of this thesis was to shed light on the role of SD in glomerular filtra-
tion by studying the function of nephrin. The precise localization of nephrin in the 
kidney and its expression profile in other tissues were investigated. Also, novel 
nephrin-associated proteins were searched. Nephrin involvement in renal diseases 
was studied by employing two experimental rat models of proteinuria: puromycin 
aminonucleoside (PA) nephrosis and Heyman nephritis (HN).  
Filtrati
on
   
Review of the literature
1.Glomerular filtration 
The kidneys are a pair of organs responsible for 
the filtration and excretion of metabolic waste 
products as well as for the maintaining water 
and pH balance of the body. The filtration 
(urine formation) regulates body fluid balance 
by affecting the electrolyte contents, osmolarity 
as well as the acidity of body fluids, and takes 
place in the kidney’s functional units, nephrons 
(Figure 1A). Each of the approximately one 
million nephrons in the human kidney consists 
of the renal corpuscle with the Bowman’s cap-
sule and the glomerulus, a proximal tubulus, the 
Henle’s loop, a distal tubulus, and a collecting 
duct (Figure 1B) (1).  
 
Glomerular filtration takes place in the outer 
zone, i.e. cortex, of the kidney (Figure 1A). 
The afferent artery, which imports 1.1 litres of 
blood every minute (approximately 20 % of the 
total cardiac output, which is more than in the 
brain) to the glomerulus, further divides into 5 – 
7 smaller capillary branches forming the tuft-
like structure of the glomerulus surrounded by 
the urinary space and the Bowman’s capsule 
(Figure 1B). Thus, the glomerulus maintains 
filtration by forming a barrier between blood 
circulation and the tubular system, which is re-
sponsible for the formation of the final urine. 
Even though approximately 180 l of ultra fil-
trate, i.e. primary urine, is produced every day, 
the final urine volume is only 1-1.5 l/day. This 
is due to the extensive reduction of approxi-
mately 99 % of primary urine during the reab-
sorbtion in the proximal and distal tubuli lo-
cated downstream from the glomerular filtration 
barrier(1).  
1.1 Endothelial layer 
The first step of filtration takes place through 
the endothelial cell layer of the capillary lumen 
wall (Figure 1C and D). There are numerous 
small openings, fenestrations, in the endothe-
lium, which are filled with negatively charged 
glycoproteins and lipids (1). Because the pore 
diameter is approximately 75 nm, blood cells 
stay in circulation, whereas water and many 
macromolecules, e.g. albumin, flow without 
restraint through the pores (2). 
 
 
Figure 1. Description of the glomerular filtration machinery in the kidney. A) Dissected kidney 
shows two separated layers: the outer cortex and the inner medulla B) A nephron is responsible for 
urine formation; glomerulus maintains the filtration by forming a filtration barrier between the uri-
nary space and blood circulation. C) Glomerular capillary lumen is covered by fenestrated endothe-
lium, glomerular basement membrane (GBM) and podocyte-derived foot (secondary) processes. D) 
Podocyte foot processes are interconnected across the filtration slit by a special structure, a slit dia-
phragm (SD). Molecular composition of the SD has been presented in detail in Figure 5. 
1.2 Basement membrane 
The second layer in the filtration barrier is the 
negatively charged glomerular basement mem-
brane (GBM) (Figure 1C and D). It presuma-
bly prevents the flow of charged molecules into 
the primary urine (3). In addition to charge se-
lectivity, GBM forms a size-selective barrier for 
particles with a size similar or larger to that of 
albumin (MW 68 kDa). GBM is composed 
mainly of Type IV collagen and laminin, but 
contains also heparan sulphate proteoglycans, 
fibronectin and entactin/nidogen (for reviews, 
see (4, 5)) 
1.3 Epithelial layer 
The last filter is composed of the visceral 
epithelial cells called podocytes. Podocytes 
have a highly specialized structure with major 
(primary) processes and foot (secondary) proc-
esses that extend from the cell body, which has 
been postulated to lie freely in the urinary space 
(Figure 1C and D). A prominent nucleus of the 
podocyte is located in the cell body that has also 
been shown to be abundant in mitochondria (1). 
Contractile secondary processes, the tentacle-
like ends of the primary processes, cover the 
basement membrane on the urinary side of the 
capillaries (Figure 1C). In contrast to the cell 
body, the foot processes contain only few or-
ganelles. The foot processes stabilize the shape 
of the glomeruli (6). They also maintain the fil-
tration surface of the podocytes by a special 
structure, the slit diaphragm (SD), which inter-
connects the adjacent foot processes. In addition 
to producing the structural components of the 
SD, podocytes together with the cells of the me-
sangium have been proposed to synthesize the 
majority of the GBM components. In many 
pathological conditions associated with protein-
uria, a continuous cytoplasmic band along the 
glomerular basement membrane replaces the 
foot processes. This phenomenon is commonly 
referred to as foot process fusion or effacement 
(1). Importantly, due to the high degree of dif-
ferentiation of mature podocytes, like neurons, 
they have not been shown to proliferate (7). 
1.4 Mesangial tissue 
The mesangial tissue between the glomerular 
capillaries consists of mesangial cells and an 
intercellular matrix. Mesangial cells contain 
contractile primary processes that attach di-
rectly to the capillaries and regulate the diame-
ter of the capillary as well as provide structural 
support for the glomeruli by contractions. The 
cell contractions are stimulated by many 
vasoactive agents and the relaxations caused by 
e.g. dopamine and atrial peptides (8). Both 
processes affect directly the blood pressure. 
Mesangial cells are abundant in myosin and ac-
tin filaments and have functional properties, 
such as phagocytic activity. They also produce 
for instance matrix components, hormones, cy-
tokines, enzymes, and lipids (9, 10).  
   
2. Filtration barrier dysfunction and 
proteinuria 
Normally small and neutral proteins pass the 
filtration barrier freely, this not being a problem 
since active reabsorbtion in the downstream tu-
bular system returns the majority of the proteins 
back into circulation. Under proteinuric condi-
tions proteins that are normally kept in the 
blood circulation leak into the urine (11). This 
results in an increased amount of total protein 
load in the tubular system, which in turn over-
loads the tubular reabsorbtion capacity and pro-
teins pass freely into the collecting duct. Auto-
immune diseases, local inflammations, toxins, 
metabolic products and genetic mutations may 
cause these conditions. Protein leakage into the 
urine is often due to dysfunction of the selective 
glomerular filtration barrier with functional or 
structural changes in the corresponding pro-
teins. However, also inhibition of the tubular 
reabsorbtion by for instance the presence of 
metal ions, leads to proteinuria (12).  
 
As a result of proteinuria, the protein concentra-
tion in plasma is reduced. In clinical work the 
levels of one of the most abundant plasma pro-
teins, albumin, can be measured in order to find 
out the severity of proteinuria. Limited amounts 
of albumin may normally be detected in the 
urine whereas increasing concentration points at 
increasing proteinuria. Albumin is one of the 
most important components maintaining os-
motic balance between the cells and inter-
stitium. Thus, in severe or extended albumin 
loss/proteinuria this balance is disturbed, lead-
ing to oedema (12).  
3.Animal models as the prototypes of 
human glomerular diseases 
Nephrotic syndrome (NS) is reflected by in-
creased amounts of proteins in the urine. Other 
clinical features of NS are hypoalbuminemia, 
hypercholesterolemia and oedema. Primary or 
idiopathic NS may be caused e.g. by minimal 
change nephropathy, focal segmental glomeru-
losclerosis, mesangial proliferative glomeru-
lonephritis, IgA nephropathy, membranous 
glomerulonephritis and membranoproliferative 
glomerulonephritis (13, 14). Secondary NS can 
be consequence of i.e. complications of other 
diseases, toxic or infectious agents. One impor-
tant group, even though rare, of NS is the con-
genital diseases including e.g. Denys-Drash 
syndrome (15), congenital nephrotic syndrome 
of the Finnish type (see chapter 4.1) and disor-
ders of the GBM (16). 
 
Experimental animal models are widely used to 
study the molecular mechanisms of a broad va-
riety of diseases in vivo. During recent years 
some of the most commonly used models are 
knock-out and transgenic mice with a proven 
capacity to reveal the functional properties of 
the molecules in the tissue. In addition to mouse 
models, experimental rat models are widely 
used and are suitable to obtaining functionally 
relevant data, especially in glomerular injury 
   
research. The advantage of the rat models is that 
they have been carefully characterized during 
the past decades and allow collection of time-
dependent tissue samples in the due process 
leading to disease.  
3.1 Minimal change nephropathy and puro-
mycin aminonucleoside nephrosis 
3.1.1 Minimal-change nephropathy  
Minimal-change nephropathy (MCN) belongs 
to the heterogenous group of disorders called 
primary glomerular diseases, in which the 
glomeruli are the only or the principal target. 
MCN is the most common cause of primary 
nephrotic syndromes (NS) in children between 
2 and 6 years of age. Typical findings are heavy 
proteinuria, hypoalbuminemia and hyperlipi-
demia. Microscopic haematuria is observed in 
about 20 percent of cases. Serious haematuria 
and hypertension are relatively uncommon (14). 
Only minor, if any, glomerular changes are 
visible under light microscopy, but in electron 
microscopy (EM) flattening of foot processes 
can be observed (17). Charge alterations in the 
filtration barrier of the MCN glomeruli have 
been detected (18); other findings include the 
presence of lipid droplets in proximal tubules. 
The pathogenesis of MCN is still unclear, but it 
has been suggested that MCN might be an auto-
immune disease (14). 
3.1.2 Puromycin aminonucleoside nephrosis 
Puromycin aminonucleoside (PA) nephrosis is a 
widely used animal model for proteinuria. In 
the PA nephrosis model, the morphological and 
functional changes are similar to human mini-
mal change nephropathy (MCN). After a single 
intravenous injection of PA into rat, proteinuria 
starts at day 3-4 and is at its maximum at day 
10. The kidney damage is reversible, and nor-
mal kidney function is regained at around day 
25 (19). Morphological changes include dilata-
tions of tubuli, thickening of the GBM, altered 
or lost SD and later on, detachment of the epi-
thelium from the GBM. Fusion and retraction as 
well as cytoskeletal rearrangement of the foot 
processes of podocytes are typical findings in 
PA nephrosis (20). Furthermore, a change in the 
expression and localization of several podocyte 
proteins has been observed (see Chapter 5).  
3.2 Membranous glomerulonephritis and 
Heymann nephritis 
3.2.1 Membranous glomerulonephritis  
Membranous glomerulonephritis (MGN) is in-
cluded in the primary glomerular diseases. The 
majority of MGN patients are adults of over 30 
years of age. Severe proteinuria and micro-
scopic haematuria are typical hallmarks in 
MGN. In light microscopy analysis, the capil-
lary wall is found thickened, and it trespasses 
into the capillary lumen. In EM studies, this has 
been shown to be caused by subepithelial and 
intramembranous immune complex deposits 
(14). The deposits alter the organization of the 
podocyte foot processes by distorting the struc-
ture. Intracapillary thrombosis is also com-
monly detected in MGN but it is thought to be a 
consequence of the MGN itself. Immunoglobu-
   
lin G and complement component C3 are fre-
quently found in the capillary loops of MGN 
glomeruli. Even though the exact pathogenesis 
of MGN is unclear, some suggestions of how 
the immune complex deposits develop have 
been made (21). The deposits may be circulat-
ing immune complexes accumulating in the 
glomeruli or they may arise due to an in situ 
reaction between circulating antibodies and an-
tigens in the glomerulus (14).  
3.2.2 Heymann nephritis 
Heymann nephritis (HN) of the rat is a model of 
immune complex-mediated glomerular damage 
(22). The HN model is analogous with the hu-
man MGN. HN is induced by injecting rats with 
proximal tubular brush border (BB) antigen, 
Fx1A, (active HN) or the anti-Fx1A antibody 
(passive HN). Accumulation of antigen-
antibody immune complexes on the podocyte 
surface activates complement C5b-9 (also 
called membrane attack complex, MAC) caus-
ing proteinuria (23, 24). Simultaneously with 
the deposit-formation of cell-damaging agents, 
reactive oxygen species (ROS), hydroperoxides, 
are produced. Thus, the proteinuria in HN could 
be reduced by inhibition of lipid peroxidation 
by treatment with the antioxidant agent probu-
col (23, 25). 
The protein affected at inducing HN is gp330, 
also called megalin, a glygoprotein of the lipo-
protein receptor family. It is expressed in 
clathrin-coated pits at the bases of foot proc-
esses of podocytes and proximal tubular cells, 
and it has been shown to function as an an-
chored receptor in the endocytotic pathway 
(26).  
3.3 Mercuric chloride model 
The kidneys are the primary organs where inor-
ganic mercuric chloride (HgCl2) is taken up. 
Thus, acute renal failure (ARF) in rats can be 
induced by exposure to HgCl2. Mercuric ions 
bind with high affinity to sulfhydryl–containing 
molecules and form conjugates with e.g. glu-
tathione and proteine cysteines in the kidneys. 
Accumulation of mercuric ions is mainly seen 
in the proximal tubule, but also other parts of 
the nephron participate in the absorbtion and 
gathering of mercuric ions (27). The primary 
effect of HgCl2 is the induction of oxidative 
processes (28). It is promoted by reduced pro-
duction of counter-balancing molecules (pro-
tecting agents), e.g glutathione, and increased 
levels of the free oxygen radical, hydrogen per-
oxide. Free oxygen radicals can induce oxida-
tion of lipids. Mercuric chloride reduces adeno-
sine triphosphate (ATP) synthesis in mitochon-
dria and is shown to induce apoptosis by caus-
ing mitochondrial dysfunction (29).  
4. NPHS1 gene and its protein product 
nephrin 
4.1 NPHS1 is mutated in congenital nephrotic 
syndrome of the Finnish type (CNF) 
Mutations in the NPHS1 gene lead to congenital 
nephrotic syndrome of the Finnish type (CNF) 
(30). CNF is an autosomal recessive renal dis-
   
ease (31-33) and is mainly found in Finland 
with an approximate incidence of 1/10000 of 
live births (34). Over 90% of NPHS1 mutations 
in the Finnish population are either Finmajor  with 
an early stop codon in exon 2 or Finminor with a 
stop codon in exon 26. A variety of different 
mutations leading to various clinical manifesta-
tions has been described also in other countries 
(35-37). In earlier times, CNF led to death dur-
ing the first months of life, but in 1984, a new 
treatment protocol was introduced. It consists of 
early nephrectomy and dialysis until the body 
weight rises to an acceptable level for transplan-
tation (38). This treatment removes all symp-
toms apparently with no later manifestations in 
other organs (39). The clinical features of CNF 
are massive proteinuria already in utero, oe-
dema, enlarged placenta and low birth weight 
(31, 40, 41). Detection of high levels of alpha-
fetoprotein in the amniotic fluid and in the ma-
ternal circulation has been used for prenatal di-
agnosis of CNF (42-44). However, after the 
finding of the causative NPHS1 gene defect, the 
diagnosis is not infallible without mutation 
analysis (45). Interestingly, after transplanta-
tion, 20% of CNF patients manifested with a 
recurrence of the nephrotic syndrome, which 
has been shown to occur due the presence of 
nephrin-specific circulating auto-antibodies (46, 
47).  
 
CNF kidneys are twice as heavy compared to 
normal, and the number and size of glomeruli 
are significantly increased (48-50). At the same 
time, the number of podocytes is decreased and 
the podocytes show effacement of the foot 
processes and absence of slit diaphragms (43). 
The glomeruli are also more dense in CNF kid-
neys than in normal kidneys (50-52). Other his-
tological findings include dilated proximal tu-
buli, mesangial hypercellularity with expansion 
of the mesangial area, inflammation, thickened 
basement membrane and thickened parietal 
epithelial cell layer of Bowman’s capsule (33, 
43, 44, 50, 51, 53). 
 
NPHS1 gene locates to chromosome locus 
19q13.1 (54, 55). The gene spans about 26 kb 
of DNA sequence and contains 29 exons, rang-
ing from 25 bp to 216 bp in length (35), and a 
recently found additional exon 271 bp in length 
located 3.7 kb upstream of the ATG translation 
initiation codon in exon 1. Thus, the originally 
reported exon 1 has been named exon 1A, and 
the additional exon, exon 1B (56). The gene 
produces a 4,3-kb long mRNA, which is trans-
lated to a protein called nephrin. 
4.2 Nephrin protein 
4.2.1 Nephrin is a member of the immu-
noglobulin superfamily 
The predicted domain structure of nephrin clas-
sifies it as a member of the immunoglobulin 
(Ig) superfamily (Figure 2). Moreover, a new 
subfamily of nephrin-like (NEPH) molecules 
including (in addition to nephrin) NEPH1, 
NEPH2 and NEPH3/filtrin has recently been 
   
described (57, 58). Structural counterparts of 
these proteins have also been identified in Dro-
sophila (59). 
 
 The group of molecules in the Ig superfamily 
shares a common structural feature, the Ig ho-
mology domain, coded by exons from 2 to 20 of 
the nephrin gene. Ig–like domains are suggested 
to be involved in protein-protein and protein-
ligand interactions. The members of this family 
are found at different levels of phylogeny, from 
insects to man. The Ig-superfamily has been 
shown to consist of hundreds of proteins with 
different functions, many of them serving as 
cell surface receptors involved in immune reac-
tions and binding of viruses and growth factors. 
Receptors of the Ig-superfamily function abun-
dantly in conjunction with other cell adhesion 
proteins including members of the integrin fam-
ily, cadherins and selectins. The finding of in-
volvement of Ig-superfamily proteins in signal 
transduction is also supported by their ability to 
associate with cytoplasmic non-receptor kinases 
(60). While the precise functions of nephrin re-
main to be characterized, it is probable that it 
shares the general functions like adhesion 
molecule and receptor function with the other 
members of the Ig family. As an example, the 
Ig-superfamily includes proteins like antibodies, 
leukocyte function antigen-2 (LFA-2 or CD-2) 
(61) and -3 (LFA-3 or CD58) (62), intercellular 
adhesion molecules (ICAMs) (63-65), vascular 
cell adhesion molecule-1 (VCAM-1) (66) and 
platelet-endothelial cell adhesion molecule-1 
(PECAM-1 or CD31) (67). The members of this 
family have also been found to function in T-
cell antigen and/or MHC recognition (68-70). 
4.2.2 Domain composition 
4.2.2.1 Signal sequence 
The first 22 amino acids encoded by exon 1A of 
the human nephrin gene form the amino-
terminal signal sequence, which is cleaved by a 
peptidase in the lumen of the endoplasmic re-
ticulum (ER) (30). However, the recently re-
ported exon 1B does not have this signal pep-
tide resulting in an altered expression profile of 
nephrin (56).  
4.2.2.2 Immunoglobulin-like domains 
The eight Ig-like domains of the extracellular 
part of nephrin are of C2 type. The Ig C2 do-
mains are from 80 to 100 amino acids in length 
and have a folding pattern distinct from the 
other Ig superfamily domains C1 and V (71). 
The C2-type subfamily includes glycoproteins 
and other unrelated proteins with Ig domains, 
e.g. carcinoembryonic antigens (72) and fibro-
blast growth factor receptors (73).
  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.Domain composition of nephrin. Nephrin sequence consists of an N-terminal extracellular 
part, a transmembrane domain and a C-terminal intracellular domain. 
 
4.2.2.3 Free cysteine residues 
Thiol group-containing cysteines can form di-
sulphide bonds with each other thus cross-
linking and stabilizing the folded protein chain. 
In addition to the cysteine residues of the Ig-
like domains, the extracellular domain of neph-
rin also contains free cysteine residues that may 
serve as linkers between binding partner(s) (30). 
4.2.2.4 Fibronectin type III-like module 
A fibronectin type III-like domain, coded by 
exons 22 and 23, is found upstream of the puta-
tive transmembrane domain, which is coded by 
exon 24. The fibronectin type III domain was 
first identified in the extracellular matrix pro-
tein fibronectin (74). The domain includes a 90-
residue module with conserved tryptophan and 
tyrosine residues in its amino- and carboxy-
terminals. The secondary structure of the do-
main is highly similar to the Ig-like fold (75, 
76). Glycoproteins of the Ig superfamily with 
fibronectin type III-like domains interact with 
each other and with other molecules of the ex-
tracellular matrix (77-79). 
4.2.2.5 Intracellular domain 
The putative cytosolic domain is coded by ex-
ons 25-29 resulting in a 155-amino acid do-
main. The presence of eight tyrosine residues in 
the intracellular domain suggests a role in sig-
nalling (see Chapter 4.5). The intracellular do-
main shows no significant homology to other 
proteins (30). 
4.2.2.6 Nephrin is N-glycosylated 
The human nephrin protein sequence has ten 
putative N-glycosylation sites, i.e. oligosaccha-
ride units can be linked to the asparagine side 
chains of the protein by N-glycosidic bonds. 
This has been postulated to occur based on the 
finding of a difference between the calculated 
   
molecular weight (MW) of nephrin (135 kDa) 
and the MW identified by PAGE and Western 
blot analysis (185 kDa) (30). Furthermore, pep-
tide N-glycosidase treatment of the glomerular 
lysate resulted in a decrease in the MW as veri-
fied by Western blotting, and the lack of N-
glycosylation affects the proper folding and 
changes the cellular localization pattern of 
nephrin (80). 
4.4 Interaction partners  
Since the wealth of evidence strongly suggested 
that nephrin is the key backbone molecule of 
the filtration barrier it has become increasingly 
important to identify the molecular complexes 
associated with nephrin and the physiological 
function of this molecular machinery. Recent 
studies have revealed CD2-associated protein, 
podocin and NEPH1 as interacting partners for 
nephrin 
4.4.1 CD2AP 
CD2-associated protein (CD2AP) was the first 
identified protein interacting with the intracellu-
lar domain of nephrin (81-83). CD2AP was 
originally identified from mouse T cells inter-
acting with the cell adhesion protein CD2 (84). 
Later, identical sequences were found in a gene 
involved in mouse kidney development (85) 
and in a gene encoding focal adhesion protein 
p130Cas-associated protein (86). CD2AP is 
widely expressed in different tissues and is in-
volved in e.g. cytoskeletal polarity of cells and 
in signalling cascades regulating cell morphol-
ogy (87). CD2AP-deficient mice develop 
nephrotic syndrome, similar to the human dis-
ease (88). CD2AP binds directly to filamentous 
actin, and this way links nephrin to the actin 
cytoskeleton (89). 
 4.4.2 Podocin 
Podocin interacts with the intracellular domain 
of nephrin. It is an integral membrane protein 
and belongs to the stomatin superfamily. 
NPHS2, encoding podocin, has been identified 
as a gene mutated in autosomal recessive ster-
oid-resistant nephrotic syndrome (90-92). Re-
duced podocin protein levels have been de-
tected in the glomeruli of PA -nephrotic rats 
(93). So far, podocin has been shown to be ex-
pressed exclusively in podocytes (94, 95) and 
has been localized to the SD (96); it also inter-
acts with CD2AP (92). Podocin has been shown 
to be anchored in lipid rafts, which are micro-
domains rich in sphingolipids and cholesterol, 
in the outer leaflet of the plasma membrane (92, 
97). Interaction with podocin affects the signal-
ling properties of nephrin (see Chapter 4.5) 
4.4.3 NEPH1 
Nephrin has recently been shown to interact 
with itself and with NEPH1 (98). NEPH1 is a 
transmembrane protein, and belongs to the 
nephrin-like Ig superfamily with five extracellu-
lar Ig-like domains. In electron microscopic 
studies, NEPH1 localizes to the lateral margins 
of podocytes and also to the SD. NEPH1 knock-
out mice present with effacement of podocyte 
foot processes, proteinuria, and the mice die 
perinatally (99). NEPH1, like nephrin and po-
   
docin, localizes to lipid rafts. The intracellular 
sequence of NEPH1 also interacts with podocin 
(57).  
4.5 Proposed functions 
Activators of the protein kinase C (PKC) path-
way increase nephrin mRNA expression in cell 
culture indicating that PKC may be the intracel-
lular signalling system regulating nephrin (100). 
Nephrin is dramatically down-regulated in mice 
with decreased levels of Wilms’ tumor gene 1 
(WT-1), suggesting that nephrin acts down-
stream of WT-1 (101). Nephrin expression trig-
gers the activation of the transcription factor 
AP-1 (57). Nephrin is localized to lipid rafts, 
which are membrane micro-domains containing 
a given set of proteins mediating activation of 
signalling cascades. Nephrin-containing lipid 
rafts also contain the antigen for the 27A anti-
body, a podocyte-specific 9-O-acetylated GD3 
ganglioside. In vivo injection of 27A antibody 
to rats causes tyrosine phosphorylation of neph-
rin (97). Recent studies have shown that neph-
rin’s cytoplasmic domain is tyrosine-
phosphorylated by the src family kinases (102, 
103). Src family kinase Fyn co-precipitates with 
nephrin and together with Yes fractionates into 
the lipid raft fraction. Furthermore, Fyn deletion 
in mice results in morphological alteration of 
podocyte foot processes (102). Interestingly, 
clustering of over-expressed nephrin on the cell 
surface induced its own Src kinase-mediated 
tyrosine phosphorylation (103). Most resent re-
port demonstrates that both nephrin and CD2AP 
interact with phosphoinositide 3-OH kinase and 
together with podocin trigger AKT signalling in 
podocytes (104). AKT mediates phosphoryla-
tion of several target proteins in podocytes, in-
cluding Bad (105).  
4.6 Monoconal antibody 5-1-6 nephropathy 
model 
The monoclonal antibody 5-1-6 (mAb 5-1-6) 
nephropathy model was introduced by Orisaka 
et al. (106) already in 1988. Recently, it has 
been concluded that mAb 5-1-6 recognizes an 
extracellular epitope of the rat nephrin homo-
logue (107). A single intravenous injection of 
mAb 5-1-6 into rat causes massive proteinuria 
and reduction in nephrin expression. However, 
in electron microscopic studies the SD displays 
normal morphology in mAb 5-1-6-nephropathic 
glomeruli (108). 
4.7 Nephrin-deficient mice models 
Nephrin deficient mice show symptoms of pro-
teinuric disease and die perinatally. Morpho-
logically, the majority of the podocytes’ foot 
processes are fused and the remaining interpo-
docyte junctions lack slit diaphragms (109, 
110). Interestingly, already in the heterozygote 
phenotype, approximately one third of the foot 
processes are fused with remarkable down-
regulation of nephrin-specific mRNA levels 
(110).  
   
5. Proteins in podocyte’s foot processes 
The podocyte foot processes have distinct api-
cal and basal compartments along the divisional 
plane of the slit diaphragm (Figure 1D). Each 
compartment has a special protein composition. 
The slit diaphragm protein complex represents a 
size-selective barrier for macromolecules (93, 
111). Adhesion proteins in the basal membrane 
of the foot processes anchor podocytes to the 
GBM and stabilize them while proteins on the 
apical side are thought to keep the adjacent cell 
membranes apart, preserving in this way the 
cell shape. The cytoskeleton is needed to main-
tain the overall architecture of the podocytes. 
This kind of compartmentalization into func-
tional domains has crucial functional properties 
in glomerular filtration (112). Interestingly, mu-
tations or deletions in proteins that localize to 
different compartments in the podocyte result in 
a podocyte phenotype resembling that found in 
foot process effacement and proteinuria (14, 88, 
99, 110, 113, 114). Hamano et al. (115) have 
proposed that alterations in slit proteins can be 
observed as a sudden plasma protein leak 
whereas changes in proteins of the basement 
membrane lead to an insidious plasma protein 
leak.  
 
Obviously, a majority of the structural and 
functional protein complexes of podocytes re-
mains to be characterized. The group of pro-
teins known to date to be involved in SD struc-
ture and function is summarized below. Some 
of the protein complexes situated in the apical 
and basal membrane compartments or in the 
cytoskeleton, and found crucial for the filtration 
function, are presented as well. 
5.1 Slit diaphragm 
The filtration slit membrane, or SD, bridges the 
gap, referred to as the filtration slit or slit pore, 
between the adjacent podocyte foot processes 
(Figure 1C and D). The SD forms a zipper-like 
structure as reported by Rodewald and Kar-
novsky (116). The architecture of the slit dia-
phragm is suggested to be mediated by protein-
protein interactions across the foot process in-
tercellular junction (117). The SD structure 
makes a selective sieve that prevents proteins ? 
albumin from leaking into urine. It is estimated 
that this surface maintains approximately 40% 
of the hydraulic resistance of the whole filtra-
tion barrier (118). 
 
The tight junction protein ZO-1 was the first 
protein found abundant in the cytosolic domain 
of the SD area (119). ZO-1 has been demon-
strated to interact with the cell-junction compo-
nents occludin, alpha-catenin and ZO-2 as well 
as with the cytoskeletal molecules spectrin and 
F-actin. Recently, interactions between ZO-1 
and NEPH family members have been reported 
with an implication that ZO-1 may serve as an 
organizer, and recruit the signal transduction 
components to the SD (120). Alterations in ZO-
1 localization and expression have been ob-
served in PA nephrosis and in the 5-1-6 neph-
   
ropathy of the rat (121). However, in CNF kid-
neys with an absent nephrin expression, ZO-1 
expression remains unaffected (117). 
 
Recently, the transmembrane proteins FAT 
(122) and P-cadherin (123) have been shown to 
locate to the SD domain. In Drosophila, FAT 
was found as a tumour suppressor gene shown 
to participate in cell proliferation. In addition to 
P-cadherin, also FAT belongs to the cadherin 
superfamily with a function similar to cell adhe-
sion molecules that mediate homophilic Ca2+-
dependent cell-adhesion. All members of the 
family have characteristic extracellular domains 
composed of multiple repeats of a cadherin-
spesific motif. So far, FAT or P-cadherin have 
not turned out to be essential for the mainte-
nance of the normal SD. P-cadherin knock-out 
mice appear with normal glomerular function 
(124), and normal expression of P-cadherin is 
detected in the glomeruli of CNF kidneys (117, 
124). If the function of other members in the 
SD protein complex, such as NEPH1, podocin 
or CD2AP, is disturbed, the structure of the foot 
processes is altered and detected as an effaced 
phenotype associated with proteinuria (see 
above Chapter 4.4). 
5.2 Cytoskeleton 
An intact submembranous actin cytoskeleton is 
needed to maintain the podocyte cytoarchitec-
ture (125, 126). In contrast with the dominance 
of microtubules and intermediate filaments in 
the cell body and in the primary processes, 
microfilaments and actin filaments beneath the 
cell membrane are present in the foot processes 
(1). Active polymerisation/depolymerisation of 
actin filaments obviously occurs constantly in 
podocytes as evidenced e.g. by the presence of 
the protein complex Arp2/3 and its activator 
cortactin in the foot processes (127, 128). 
Arp2/3 binds to actin filaments and allows the 
growth of new branching filaments (129, 130).  
 
Actin filaments are cross-linked by alpha-
actinin, which connects the actin cytoskeleton 
to the cell membrane. Non-muscle isoforms of 
alpha-actinin include alpha-actinin-1 and –4. Of 
these, alpha-actinin-4 is widely expressed (131) 
and is found also in glomerular podocytes 
where it localizes to the foot processes (126). Its 
central role in the foot processes is evident, 
since mutations in the ACTN4 gene lead to fa-
milial focal segmental glomerulosclerosis 
(FSGC) (132). The typical morphological find-
ings of this kidney disease include flattening of 
the podocytes and detachment of foot processes 
from the GBM (14). In the PA nephrosis, rear-
rangement of the cytoskeleton is seen (125, 
133), and the mRNA expression level of 
ACTN4 is indeed increased (126), but the cor-
responding protein level is similar to that in 
normal rat glomeruli (93). Recently, Kos et al. 
(134) reported on a severe glomerular disease 
with disrupted podocyte morphology and pro-
teinuria in alpha-actinin-4-deficient mice. Inter-
estingly, despite ubiquitous expression of alpha-
   
actinin-4 its deficiency resulted in histological 
abnormalities only in the kidney.   
 
Synaptopodin colocalizes with actin microfila-
ments in podocyte foot processes (135). Synap-
topodin is postulated to be a marker of the ma-
ture podocyte (136). Down-regulation of synap-
topodin expression in idiopathic nephrotic syn-
dromes and in CNF glomeruli implies its impor-
tance for normal podocyte function (137). 
5.3 Basal cell membrane region 
The basal aspect of the podocytes forms an im-
portant cell domain anchoring cells to the 
GBM. The mechanisms and molecules involved 
in basal region have only recently been identi-
fied. 
5.3.1 Dystroglycan protein complex   
After synthetization, dystroglycan is post-
translationally cleaved into the transmembrane 
?-dystroglycan and the heavily glycosylated 
peripheral membrane ?-dystroglycan. These 
two proteins are non-covalently linked. A larger 
dystroglycan protein complex including dystro-
phin, syntrophin, ?-, ?? and???-sarcoglycan com-
plexes as well as sarcospan, has originally been 
isolated from skeletal muscle (138, 139). This 
complex mediates a connection between the 
extracellular matrix and the actin cytoskeleton 
(140, 141). Presence and localization of dystro-
glycan, sarcoglycan, agrin and utrophin (an 
autosomal homologue of dystrophin) in the kid-
ney could represent an epithelial complex (142-
144) 
 
It is postulated that ?-dystroglycan binds via 
utrophin to F-actin in the podocytes (143, 145). 
However, studies by Durbeej and Campbell 
(146) show that ??sarcoglycan and utrophin are 
not integral components of the kidney’s dystro-
glycan complex in adult, but only in fetal kid-
ney. ?-dystroglycan is differently glycosylated 
in fetal and adult kidney (146)??and binds, in ad-
dition to the extracellular portion of ?-
dystroglycan, also to laminin 1 (alpha-5) (146) 
(142), perlecan and agrin in the GBM (147).  
5.3.2??3?1-integrin complex 
Integrins belong to the widely expressed family 
of cell surface proteins that attach cells to the 
extracellular matrix. The binding of subunits ? 
and ? results in a heterodimer typical of in-
tegrins (148). In podocytes, actin, myosin, al-
pha-actinin, paxillin, vinculin and talin are con-
nected to the GBM at focal contacts (basal cell 
membrane) through an ?3?1-integrin complex 
(149, 150). The ?3?1-integrin complex adheres 
to the ECM proteins laminin, proteoglycans 
agrin and perlecan, type I and IV collagen, fi-
bronectin and entactin/nidogen in GBM (151). 
?1-integrin connects to the actin cytoskeleton 
via alpha-actinin-1 (152). In mice lacking al-
pha-3 integrin, early onset of massive proteinu-
ria is observed (113). Remarkable up-regulation 
in the protein expression level of ?1-integrin 
   
has been reported regarding the glomeruli of PA 
nephrotic rats (93). 
5.4 Apical membrane region 
5.4.1 Podocalyxin/Ezrin/NHERF2 and WT-1 
The apical compartment, the anionic pole of the 
podocytes, maintains an electrostatic repulsion 
barrier in the glomeruli. A negative net charge 
of the adjacent cell surfaces keeps the intercel-
lular space open (153). Repulsion is mainly due 
to the integral membrane protein, podocalyxin, 
which is abundantly found in podocytes (154-
159). Podocalyxin is highly glycosylated by N- 
and O-linked carbohydrates, which are heavily 
sialylated and sulphated; these residues give a 
negative net charge to the protein (160). Podo-
calyxin is connected to the actin cytoskeleton 
through a complex of ezrin and Na+/H+-
exchanger regulatory factor 2 (NHERF2) (161). 
Ezrin is a member of the ezrin-radixin-moesin 
(ERM) family of cytoskeletal linker proteins 
involved in the maintenance of epithelial cell 
polarity (162-164). NHERF2 is a regulator of 
the plasma membrane protein NHE-3, the 
epithelial isoform of the Na+/H+ exchanger fam-
ily proteins (165, 166), involved in sodium ab-
sorption in renal epithelial cells (167).  
 
The WT-1 transcription factor regulates the ex-
pression of podocalyxin in podocytes, (168). In 
several glomerular diseases, the presence of po-
docalyxin in the urine correlates with the degree 
of podocyte injury (169).  Podocalyxin gene-
deficient mice fail to form foot processes, as 
well as SD, and die neonatally (114). In the rat 
PA nephrosis model, the degree of sialylation of 
podocalyxin is reduced. This, together with de-
creased podocyte plasmalemmal surface area, 
leads to reduced total glomerular sialic acid 
content (170). In addition, podocalyxin-
NHERF2-ezrin interaction with the actin cy-
toskeleton is disrupted in podocytes of the PA 
nephrosis model (161).  
5.4.2 GLEPP1 
Glomerular epithelial protein 1 (GLEPP1) is a 
podocyte-specific receptor membrane protein 
tyrosine phosphatase (PTPase) proposed to have 
a role in podocyte function and structure by 
regulating tyrosine phosphorylation of podocyte 
proteins (171, 172). Structural changes in the 
glomeruli of GLEPP1-deficient mice include 
blunting and stretching of the podocyte foot 
processes. Furthermore, glomerular nephrin 
content and glomerular filtration surface area 
and rate are reduced in these mice. However, 
there are no detectable changes in the urine al-
bumin levels of GLEPP1 knock-out mice (172). 
In the rat PA nephrosis model, GLEPP1 protein 
and mRNA levels are reduced (173).  
6. Densin 
6.1 Expression profile 
Densin was originally purified from a postsy-
naptic density (PSD) fraction of rat forebrain 
(174). The PSD is an electron-dense thickening 
just beneath the postsynaptic membrane.  
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Domain composition of densin. Densin protein sequence predicts an extracellular part, a 
transmembrane domain and an intracellular part. 
 
 
This subcellular fraction can be prepared after 
detergent extraction of synaptosomes (175, 
176).The main function of PSD proteins is pos-
tulated to be the maintenance of adhesion be-
tween presynaptic and postsynaptic membranes 
at glutamatergic synapses (177, 178).  
 
Densin-180 has shown to be highly brain-
specific with higher expression in the forebrain 
than in the cerebellum (174). The mature pro-
tein contains 1495 amino acids with a calcu-
lated molecular weight of 167.5 kDa. An appar-
ent transmembrane domain has been suggested 
(174), but there is still discrepancy as to 
whether densin is a transmembrane or cytosolic 
protein (179). Several splicing variants of 
densin mRNA are expressed (180). One of the 
splice variants, termed LRRC7, has shown to be 
ubiquitously expressed (181). The LRRC7 
cDNA encodes a putative 216-amino acid pro-
tein with a predicted molecular mass of 25 kDa. 
6.2. Domain composition 
6.2.1 Densin is a member of LAP protein 
family 
Densin is a member of the LAP (leucine-rich 
repeats (LRRs) and PDZ domains) protein su-
perfamily with 16 leucine-rich repeats, a sia-
lomucin domain and one PDZ domain (Figure 
3). LAP family members are epithelial proteins 
with a crucial function in maintaining cell shape 
and apical-basal polarity. They also play an es-
sential role in carrying their interacting partners 
to specific plasma membrane domains (182, 
183). The LRRs in these proteins are located in 
the amino terminus with higher relation to each 
   
other than to LRRs of other proteins. In densin, 
like in other typical LRR-containing adhesion 
molecules, cysteine-rich domains flank the 
LRRs. However, the cysteine clusters of densin 
do not match the typical consensus of LRR-
containing proteins (184). In addition to densin, 
three additional LAP proteins have been re-
ported in vertebrates: erbin (185), scribble (186) 
and lano (187).   
6.2.2 Leucine-rich repeats  
Leucine-rich repeats (LRRs) are short, 22- to 
28- residue motifs in a variety of cytoplasmic, 
membranous and extracellular proteins with di-
verse functions. A common property of the 
LRR motifs is protein-protein interaction e.g. in 
hormone-receptor connection, enzyme inhibi-
tion, cell adhesion, cellular trafficking and vas-
cular repair (188, 189). According to the three-
dimensional structure of the LRR domains, it is 
possible that they form structures capable of 
interacting with membranes (190). 
6.2.3 PDZ domains 
PDZ domains were first identified in the post-
synaptic density protein 95 (PSD-95), the Dro-
sophila melanogaster discs large protein (DLG) 
and the zonula occludens 1 protein (ZO-1) con-
tracting to form the name PDZ according to the 
first letters of the name in these proteins. Addi-
tional names for the domain are DHR (accord-
ing to Discs large Homology Repeat) and 
GLGF (after the highly conserved four-residue 
GLGF sequence within the domain). PDZ do-
mains are about 90 residues in length and are 
conserved structural elements present as single 
or repeated copies in a variety of proteins (191). 
The PDZ domain functions as a protein-protein 
interaction module, and is currently appreciated 
as a central organizer of protein complexes at 
the plasma membrane.  
 
PDZ domains are highly sensitive for specific 
C-terminal peptide motifs. (192, 193). Densin 
PDZ domain represents type I. The binding of 
these class I PDZ domains is mediated by a 
(S/T)X(V/L) (S for serine, T for threonine, V 
for valine and L for leucine) motifs found in the 
carboxyl-termini of their binding partners (194). 
In addition to binding to specific C-terminal 
sequences, PDZ domains are capable of inter-
acting with internal peptide fragments of the 
target proteins (195-197). Binding of two PDZ 
domains on separate proteins could facilitate 
heterodimerization or complex formation (198). 
Interleukin-16 is the only secreted member of 
the PDZ protein family reported thus far (199).  
6.2.4 RGD peptide 
The Arg-Gly-Asp (RGD) tripeptide sequence 
was first described in fibronectin as a sequence 
mediating cell attachment (79, 200) via binding 
to integrins. Later on, RGD has been identified 
from several proteins also as a sequence not 
involved in attachment (201-203). 
6.2.5 Mucin-like domain 
A specific, 90 amino acids long domain in the 
extracellular part of densin is rich in serine, 
threonine and proline (174). The composition of 
   
the sequence is similar to that found in mucines 
and is termed mucin-like domain. It is present 
in many proteins and is a target region for O-
glycosylation (204). 
6.3 Interaction partners  
Densin PDZ domain has been shown to interact 
directly with the actin-binding and crosslinking 
cytoplasmic protein, alpha-actinin-4 (205). An-
other reported interaction partner is the (alpha)-
subunit of Ca2+/calmodulin-dependent protein 
kinase II (CaMKII) (174, 180, 205). CaMKII is 
identified, like densin, as a PSD fraction protein 
in synapses involved in calcium influx and syn-
aptic plasticity (206, 207). Densin interaction 
has been shown with adherens junction protein 
delta-catenin/neural plakophilin-related arma-
dillo repeat protein (NPRAP) at synapses where 
densin has been observed to co-
immunoprecipitate with delta-catenin/NPRAP 
and N-cadherin. (179). Recently, the densin 
PDZ domain was reported to interact with the 
membrane-associated guanylate kinase 
(MAGUK)-interacting protein MAGUIN-1, a 
protein that binds to PDZ domains of the synap-
tic scaffolding molecules (S-SCAM)/MAGI-2 
and to another MAGUK protein in the PSD 
fraction, the 95-kDa postsynaptic density pro-
tein (PSD-95) (208).  
7. Pancreas 
The pancreas is an organ that measures 25 cm 
long, 5 cm wide and 1-2 cm thick. Histologi-
cally it can be divided into exocrine and endo-
crine parts, both of them involved in secretion 
of enzymes and hormones (209).  
7.1 Exocrine pancreas 
The exocrine pancreas consists of special struc-
tures called pancreatic acini. Each acinus con-
sists of three to four centroacinal cells sur-
rounded by approximately 40-50 acinar cells. 
The acinar cells produce large amounts of en-
zymes including pancreatic amylase, pancreatic 
lipase, ribonuclease, DNase, proenzymes 
trypsinogen, chymotrypsinogen, procar-
boxypeptidase and elastase (210). The cells also 
produce a trypsin inhibitor to protect the cells 
from intracellular activation of protein pepti-
dase trypsin. Accidental activation of digestive 
enzymes within the cytoplasm of the acinar 
cells leads to serious acute pancreatitis. The 
centroacinal cells in the acinar lumen contribute 
to the first part of the duct system by forming 
intercalated ducts, which outside of the acinus 
lumen join each other and form intralobural 
ducts. These ducts then converge to form inter-
lobural ducts that later connect to the main pan-
creatic duct (209).  
7.2 Endocrine pancreas 
The endocrine pancreas is mainly composed of 
special structures called islets of Langerhans. 
These structures consist of five types of cells 
that do not exhibit any unusual morphologies 
but each cell type has different function in the 
pancreas. The most abundant cell type in the 
   
islets of Langerhans are the insulin-producing 
??cells. The ??cells are concentrated to the 
center but are in minor amounts also found 
throughout the islets. Secreted insulin hormone 
binds to its receptor and activates glucose take-
up especially on skeletal muscle, liver and adi-
pose cells in order to decrease blood sugar lev-
els (210). Diabetes mellitus is a disease charac-
terized by hyperglycemia, lack of insulin pro-
duction in the pancreas or inhibition insulin re-
sistance in target cells and tissues. Diabetes of-
ten leads to secondary complications, including 
blindness (diabetic retinopathy), gangrenes (dia-
betic angiopathy), myocardial infarctions 
(mmicroangiopathy/endothelial changes) and 
renal complications (diapetic nephropathy) 
(210). 
One fifth of the islet structure is composed of 
?-cells, which are located in the periphery. 
These cells produce the peptide hormone gluca-
gon. In liver hepatocytes glucagon activates the 
breakdown of glycogen to glucose, thus increas-
ing the blood sugar level (209, 210).  
 
Minor amounts of additional cell types are scat-
tered throughout the islets. ?- cells produce 
somatostatin hormone, which inhibits the re-
lease of endocrine hormones in ?-and ??cells. 
In addition, somatostatin reduces contractions 
in the alimentary tract and gall bladder smooth 
muscles. G cells release gastrin that stimulates 
production of HCl. PP cells produce pancreatic 
polypeptide that inhibits exocrine secretion of 
pancreas (209, 210).?
 
 
 
   
Aims of the study 
 
 
NPHS1 gene, encoding nephrin protein was cloned in 1998 and its mutations were 
shown to be responsible for the monogenic kidney disease, CNF. Because of the 
dramatic effect of these mutations, i.e. massive proteinuria, it was obvious that 
nephrin has an important role in maintaining glomerular filtration function. 
  
The specific aims of the thesis are as follows: 
- to clone the rat nephrin homologue  
- to show the specific localization of nephrin in glomeruli 
- to study the role and functional genetics of nephrin in proteinuric rat models 
- to search for nephrin expression in other tissues in addition to the kidney 
- to establish nephrin-associated proteins 
   
Materials and methods
1. Tissue samples 
All procedures used here were approved by the 
ethics committee of the Helsinki University 
Central Hospital, or in the case of animal stud-
ies, the ethics committee of the University of 
Helsinki.  
1.2 Normal human and CNF kidneys (II, V) 
Cadaver (n = 5; age of donors, 12–48 years) 
kidney tissues, inappropriate for transplantation 
because of failure in vascular anatomy, or the 
intact areas of removed Wilm’s tumour kidneys 
(n = 2; ages, 3 and 5 years) were used (Depart-
ment of Surgery, University of Helsinki). 
To study CNF kidneys, patients with typical 
symptoms including placental weight >40% of 
the weight of the newborn, oedema and massive 
proteinuria, were rendered to kidney nephrec-
tomy as described earlier in a special treatment 
protocol (39). Other types of congenital 
nephroses were excluded later based on typical 
pathology.  
 
After removing the kidney medulla, the cortex 
was used as such or further prepared for glome-
rular isolation. Part of the kidney material was 
always stored at –70°C. 
1.3 Human pancreatic tissue and RNA (IV) 
Cadaver pancreatic tissues were used (Division 
of Transplantation Surgery, University of Hel-
sinki, Helsinki, Finland). The isolated islets of 
Langerhans with 50 – 60 % of beta cells, as 
well as islet total RNA, were kind gifts from Dr. 
D. Eizirik (Free University of Brussels, Bel-
gium) 
1.4 Human brain tissue (V) 
The human brain sample was from normal tis-
sue of a young adult’s temporal lobe removed 
during tumour surgery, provided by Dr. Anders 
Paetau (University of Helsinki, Faculty of 
Medicine, Department of Pathology) 
 
2. Rat animal models (I,III) 
The rats in the PA nephropathy study were di-
vided into six differentially treated groups (six 
rats in each group) with a single intraperitoneal 
injection of 1) PA, 2) HgCl2 or 3) both PA and 
HgCl2. One of the groups was treated with 4) 
daily doses of the antioxidant agent probucol 10 
days before the PA + HgCl2 injection and one 
with 5) daily doses of probucol following injec-
tion, not with PA and HgCl2  but with 0,9 % sa-
line in equal amounts. The control animals 6) 
were injected with saline alone. Following sam-
ple collection and analysis are detailed in the 
original work III. 
 
Autoimmune Heymann nephritis and nitric ox-
ide synthase variation were induced in the rats 
   
as described by Uhlenius et al. (211) and in the 
original publication (Study III). 
 
In all settings mentioned above, after the re-
moval of the kidney medulla, the cortex was 
used as such for mRNA isolation. Part of the 
cortex material was stored at –70°C for im-
munofluorescence and immunoelectron micros-
copy studies. 
3. Glomerular isolation 
Glomeruli from human and rat cortex were iso-
lated using the sieving method (212, 213). Fresh 
or frozen cortex was cut into macroscopic ho-
mogeneity in ice-cold PBS. The resulting tissue 
homogenate was pressed through the 250-µm 
and 150-µm sieves by rinses with ice-cold PBS. 
Glomeruli were collected from the 106-µm and 
75-µm filters, and the purity of the isolation 
was checked under light microscope. A typical 
purity for glomeruli collected from the 106-µm 
sieve was about 90 %, whereas much higher 
purity was found for the glomeruli collected 
from the 75-µm sieve.  
4. Cell culture 
Human podocytes were isolated from normal 
human kidney as described earlier (214, 215) 
Briefly, isolated glomeruli were suspended in 
D-MEM containing 10% heat-inactivated FCS, 
2.5 mM glutamine, 0.1 mM sodium pyruvate, 5 
mM HEPES buffer, 1 mg/ml streptomycin, 100 
U/ml penicillin, nonessential amino acids (0,1x 
dilution made from 100x; all Seromed, Berlin, 
Germany), insulin, transferrin, and a 5-mM so-
dium selenite supplement, and were incubated 
at 37°C (5% of CO2). Cell colonies sprouted 
around the glomeruli were excised and incu-
bated in 5 ml of 0.2% collagenase IV (Sigma-
Aldrich, Deisenhofen, Germany) at 37°C for 30 
min followed by washes and further plating.  
The cells showed an epithelial morphology and 
stained positive for the Wilm’s tumour Ag 
(WT1) and nephrin, markers found only in po-
docytes of the adult kidney. The cells were also 
negative for the endothelial cell marker factor 
VIII-related antigens. 
5. Antibodies  
Production and characterization of anti-nephrin 
primary antibodies is described in detail in the 
original publications I-V and anti-densin pri-
mary antibodies in reference (179). Commercial 
primary and secondary antibodies are described 
in the original publications as well.  
6. Molecular biological methods 
RNA- or DNA-based molecular biological 
methods used in the original publications of this 
thesis are summarized in table I.
 
 
 
   
Table I. Molecular biological methods used in this thesis 
 
Methods Original publi-
cations 
References 
Analysis for the Finmajor (in exon 2) and Finminor (exon 26) 
mutations in NPHS1 gene 
II (30) 
RNA isolation and cDNA synthesis  I, II, III, IV, V  
Reverse transcription-polymerase chain reaction (RT-
PCR) with 
1) Rat nephrin primer sequences  
2) Human nephrin primer sequences  
3) Human densin primer sequences  
4) Rat densin primer sequences  
 
 
I, III 
II, IV 
V 
V 
 
Semiquantitative (RT-PCR) I, III, V (216) 
Sequencing of PCR products or isolated plasmids I, II, III, IV, V  
Human tissue dot blot IV  
Construction of the probe for the 3' end of human nephrin 
(HN3') and the 5' end of rat nephrin (RN5') 
I, IV  
 
 
7. Cloning of rat nephrin cDNA (I) 
Cloning of the rat nephrin homologue was per-
formed in order to produce tools for studying 
nephrin in rat models. For that purpose, a rat 
glomerular cDNA library (217) was used to 
achieve a greater portion of mRNA originated 
from podocytes. The library was plated onto 
petri-dish and further transferred onto a nylon 
membrane (Hybond N+; Amersham Life Sci-
ences, Buckinghamshire, England), according 
to the instructions of the manufacturer. Prehy-
bridization was performed at +42° C followed 
by hybridization in the hybridization solution 
containing the HN3’ probe labelled with [alpha-
32P] CTP (3000 Ci/mmol, 10 mCi/ml; Amer-
sham). After an overnight hybridization, the 
filter was washed and exposed onto the film 
(Fuji Photo Film, Japan). Positive plaques were 
picked up and used for successive rounds of 
screening with the nephrin-specific probe 
HN5’. After the single-clone excision protocol 
(ZAP Express cDNA Gigapack II Cloning kit; 
   
Stratagene), the DNA of the pBK-CMV 
phagemid clone was isolated (Quiagen plasmid 
Mini Kit; Quiagen, Hilden, Germany) and se-
quenced from three clones along both strands, 
and the sequences were screened for homology 
with database sequences, using the BLAST 
search algorithm at the National Center for Bio-
technology (Washington DC, USA)  
8. Immunochemical techniques 
8.1 Immunofluorescence (I,II,III,IV,V) 
Frozen tissue sections were cut at 5 µm and 
fixed with acetone, methanol or paraformalde-
hyde (PFA). After incubation with the respec-
tive primary antibody a FITC-or –TRITC-
conjugated secondary antibody was used. 
Washes after fixation and antibody incubations 
were performed five times in PBS. Finally, 
Immu-Mount embedding medium-covered 
(Shandon, Pittsburgh, PA) sections were ana-
lysed with an Olympus OX50 fluorescence mi-
croscope (Olympus Optical GmbH, Hamburg, 
Germany). 
8.2 Immunoelectron Microscopy (II, III) 
Immunoelectron microscopy was performed as 
described earlier (218). Briefly, fixation of 
normal cortex was employed for six hours in 
4% formaldehyde in phosphate-buffered saline 
at 20°C. After embedding with Lowicryl K4M 
(Chemische Werke LOW1,Waldkraiburg, Ger-
many), 1-micron sections were cut. These sec-
tions were blocked with 1 % ovalbumin for 1 
hour followed by incubation with the primary 
antibodies and the relevant 10-nm gold conju-
gate (1:50). 
8.3 Immunoblotting (I,II,III,IV,V) 
Protein lysates were suspended into reducing 
Laemmli buffer (62,5mM Tris-HCl (pH 6,8), 
10% glycerol, 2% SDS, 5 % 2-mercaptoethanol, 
0,05 % bromophenol blue) and heat-denaturated 
at 100 °C for 10 minutes. The proteins were 
electrophoresed in sodium dodecyl sulphate 
(SDS) polyacrylamide gel under reducing con-
ditions and electrotransferred onto a nitrocellu-
lose membrane (Scleicher & Schuell, Dassel, 
Germany). Unspecific binding was blocked by 
incubation in 3% bovine serum albumin or 5 % 
fat free milk. Primary antibody diluted in the 
same solution was hybridized, this followed by 
incubation with the horseradish peroxidase-
conjugated secondary antibody. Washings be-
tween and after the antibody incubations were 
performed in PBS. Visualizations of the bound 
antibodies were performed using the ECL blot-
ting kit (Amersham LifeScience, Amersham 
International, Buckinghamshire, GB) or the Su-
perSignal®West Pico Chemiluminescence Sub-
strate kit (Pierce, Rockford, USA).  
8.4 Immunoprecipitations (II, V) 
Possible interactions of occluding and ZO-1 
with nephrin were studied by co-
immunoprecipitations in study II. For immuno-
precipitation, the glomerular lysate (1 mg/ml) in 
radioimmunoprecipitation assay buffer was in-
   
cubated with antibodies against occludin or ZO-
1, using 10µg of IgG/200 µl of glomerular lys-
ate at 4°C overnight. Immune complexes were 
collected with protein-A-Sepharose (Pharmacia 
LKB Biotechnology), washed, and processed 
for immunoblotting with anti-nephrin antibod-
ies. 
In order to find interacting partners for nephrin, 
co-immunoprecipitation with anti-nephrin anti-
bodies was performed. Thus, freshly-isolated rat 
or frozen human glomeruli were homogenized 
in TNE buffer (250 mM NaCl, 5 mM EDTA, 10 
mM Tris, pH 7.4) with 0,2% Triton X-100 un-
der +4°C, and the resulting homogenate was 
pelleted by centrifugation and homogenized 
similarly once more. The supernatant and the 
pellet homogenate were pooled and passed 
through a 25G needle. After a 45-minute incu-
bation on ice the lysate was centrifuged at 
14000 rpm with an Eppendorf centrifuge fol-
lowed by supernatant preclearing by Sepharose 
4B protA beeds for 1 hour at +4°C. Protein A 
beeds were collected and 20µl of anti-nephrin 
antiserum were added, #050 (see Study V) to 
the rat trial and #1109 (see Study V) to the hu-
man glomerular sample. After an o/n incubation 
at +4°C, protein A was added followed by 
washes with homogenization buffer. Finally, 
Laemmli sample buffer was added to the 
washed beeds and the mixture was heated for 
10 min at 100°C followed by SDS-PAGE. 
9. MALDI-TOF-MS  (V) 
9.1 Sample preparation  
Samples immunoprecipitated with anti-nephrin 
antibodies from rat glomeruli were applied on 
8% SDS-PAGE and stained according to Blum 
et al. (219). The stained protein band close to 
200 kDa of size was excised from the gel and 
further cut into small pieces followed by the 
treatment earlier described by O’Connel and 
Stults (220). Briefly, the stain was removed 
with 0,2 M NH4HCO3/ACN solution (1:1) at 
37°C for 45 min followed by an additional 
ACN treatment and drying in a vacuum centri-
fuge. The disulphide bonds were reduced using 
55 mM iodoacetamide in 0,1 M NH4HCO3 at 
RT in the dark. The pieces were washed using 
0,1 M NH4HCO3 and H2O with ACN shrinking 
between and final drying under vacuum.  Tryp-
sin digestion was performed o/n at 37°C with 
0,05 µg/µl sequencing grade-modified trypsin 
(Promega, Madison, USA) followed by peptide 
extraction from the gel by 0,1% TFA/ 60% 
ACN 30 min at 37°C. After additional 0,1 % 
TFA treatment, the peptides were desalted in a 
Zip tip and ?-cyano4-hydroxy cinnamic acid 
was added. This mixture was used in the mass 
analysis. 
9.2 Peptide mass analysis  
Fingerprinting for the trypsinized peptides was 
performed with BiflexTM mass spectrometer 
(2GHZ digitizer) (Bruker, Rheinstetten, Ger-
many) at the Protein Chemistry unit in Bio-
   
medicum, University of Helsinki. A positive ion 
reflector mode was used with an accelerating 
voltage of 19 000 V, and a delayed extraction of 
2 ns. Internal peptide calibration standards 
(Bruker Daltons, Bremen, Germany) were ap-
plied to obtain higher peptide mass accuracy. 
The list of peptide masses obtained in MALDI-
TOF-MS analysis was used to search the NCBI 
database using the ProFound software (Version 
4.10.5, Rockefeller University). 
 
 
 
 
 
 
 
 
   
Results  
 
1.  Rat nephrin cDNA 
A cDNA library prepared from one-month old 
isolated rat glomeruli was used to clone the 
cDNA transcript with homology to human 
nephrin. With a human 5’-probe several posi-
tive clones were found and by using a rat-
specific 5’-probe, a full-length clone was ob-
tained. The 1234-bp coding region of the full-
length transcript revealed 83 % identity with the 
open reading frame of the human nephrin se-
quence (30) while the predicted aa sequence 
was 89% identical with human nephrin (Study 
1, Figure1). The transmembrane domain 
showed the highest identity, 99%, whereas the 
intracellular domain showed 83 % identity, and 
the score for the extracellular domain was 90 %. 
The predicted structural Ig-like domains were 
highly conserved, as well as the fibronectin type 
III-like module. Up to 10 putative N-
glycosylation sites were found and were identi-
cally localized between human and rat. Also a 
putative signal sequence was found in the N-
terminus of both nephrins. The locations of the 
cysteine residues were also highly identical be-
tween human and rat with the exception that the 
rat sequence had two additional cysteines at po-
sitions 192 and 356.  
 
In the immunofluorescence studies utilizing the 
intracellular nephrin peptide antibody, a typical 
epithelial staining was demonstrated in rat 
glomeruli (Study I, Figure 5 and, Study III, 
Figure 4A). Also in Western blot analysis, a 
band with an equal size to human nephrin (30) 
was observed from isolated rat glomerular lys-
ate (Study I, Figure 6 and Study V, Figure 
1A). With RT-PCR studies of rat kidney, a 
strong expression of nephrin-specific mRNA 
was detected (Study I, Figure 3). These results 
demostrated that the found clone had homology 
to human nephrin and that nephrin is also ex-
pressed in rat glomeruli.  
2. Nephrin splicing variants 
In addition to the whole length sequence, alter-
natively spliced transcript forms of nephrin 
mRNA, nephrin -??????????and -? could be de-
tected in the rat (Study I, Figure 2). According 
to sequence analysis, nephrin -??and????could 
putatively be translated in a correct open read-
ing frame. When compared to the human se-
quence (35), ?-nephrin lacks the transmem-
brane domain coding for exon 24 and for the 
intracellular exons 25, 26 and 27. ?-nephrin 
lacks part of the exon 24 (bp 3166 – 3205). 
??nephrin ?was ?also found to be expressed?in 
human, but in contrast to rat, ?it lacks specifi-
cally and only the transmembrane-coding exon 
24 (Study II, Figure 5).  
   
3. Nephrin localization 
Immunohistochemical studies of human or rat 
cortex sections with an antibody directed 
against the intracellular portion of nephrin 
showed glomerular staining while the basement 
membrane, the endothelium, mesangium and 
tubuli remained unstained. Positive staining of 
glomeruli was detected in the elements facing 
the urinary space visualized by finely granular 
dotted lines preferentially seen in staining with 
podocyte-specific antibodies (Study I, Figure 
5B and Study II, Figure 1B). Further electron 
microscopic studies with the same anti-nephrin 
antibodies revealed labelling of podocyte foot 
processes at the level of the SD (Study II, Fig-
ure 2 and Study III, Figure 5). Some minor 
accumulation was detected also in the plasma 
membrane of the apical surface of the secon-
dary processes.  
4. Nephrin involvement in animal mod-
els of proteinuria 
Animals treated with puromycin aminonucleo-
side (PA) started to develop albuminuria at day 
3, reaching a maximum at day 9 after the PA 
injection (Study III, Figure 1). In nephrin 
mRNA expression, a 40% down-regulation at 
day 3 (P = 0.037) and an 80% down-regulation 
at day 10 (P = 0.027) were detected (Study I, 
Figure 4; Study III, Figure 2 and Study III, 
Figure 3). A decrease in nephrin mRNA level 
was also seen in the mercuric chloride-treated 
rats (Study III, Figure 2 and Study III, Fig-
ure 3), even though with the dosage of HgCl2 
used, the urinary albumin did not exceed 1.5 
mg/day (Study III, Figure 1). This rate is close 
to that of the controls in the group with com-
bined PA and mercuric chloride treatments. In 
this combination group an even more distinct 
down-regulation in the nephrin mRNA level 
was detected as early as at day 3, while the level 
of urinary protein remained unaltered. Pre-
treatment with probucol did not prevent pro-
teinuria in the PA/HgCl2 group. With the pro-
bucol dosage used alone the resulting changes 
in the nephrin mRNA level remained negligible 
(1.4- and 1.35-fold increase) at days 3 and 10, 
respectively. In Heymann nephritis, untreated 
rats or those treated with a NOS inhibitor failed 
to show any significant changes in nephrin 
mRNA expression levels. 
 
In immunohistochemistry (Study III, Figure 4 
and Table 2), an irregular and less intense pat-
tern of reactivity with anti-intracellular nephrin 
antibodies was observed in the PA nephrosis 
group in the sample taken at day 10, whereas 
insignificant changes were detected at day 3. 
Only a slight change in staining pattern was ob-
served in the Heymann nephritis and HgCl2 
groups. End-point titration was used in semi-
quantitation and two independent observers 
measured the staining intensity in tissues.  
As mentioned above, in immunoelectron mi-
croscopy the anti-intracellular nephrin antibod-
   
ies primarily recognized the filtration slit do-
main in podocytes. However, 27 % of the im-
munogold particles were regularly observed 
also along the apical plasma membrane. In PA 
nephritic rats, a significantly increased amount 
(87%) of the particles was detected on the api-
cal surface (Study III, Table 3). In Heymann 
nephritic kidney, the gold particles were also 
found in intracellular vacuoles (Study III, Fig-
ure 6). 
5. Expression profile of nephrin 
The tissue distribution studies of nephrin with 
the human RNA Masterblot and with RT-PCR 
revealed mRNA expression, in addition to hu-
man foetal and adult kidney, in the human pan-
creas and in the rat spleen (Study I, Figure 3 
and Study IV, Figure 1). In the pancreas, 
nephrin and ?-nephrin mRNA expressions were 
detected in the islets of Langerhans (Study IV, 
Figure 2). The dominant form in the pancreas 
as well as in the kidney was the full-length 
nephrin. 
 
In immunoblotting studies with anti-nephrin 
antibodies, a band at 165 kDa was detected 
from the pancreas and the islets of Langerhans 
(Study IV, Figure 3). In immunofluorescence 
studies, nephrin localized to the islets of 
Langerhans, specifically to insulin-positive 
beta-cells (Study IV, Figure 4). The immuno-
reactivity in Western blot and immunofluores-
cence analysis was abolished by pre-incubation 
of the anti-nephrin antibody with the corre-
sponding antigen.  
6. Nephrin-associated molecules 
In order to search for additional podocyte mole-
cules interacting with nephrin immunoprecipita-
tion of rat glomerular lysates with anti-nephrin 
antibodies was done. Proteins of the precipitate 
were separated in SDS-PAGE, silver stained 
and identified with MALDI-TOF mass spec-
trometry. Of the peptide masses obtained, 11 
matched with rat densin originally identified 
from the forebrain and thought to be expressed 
exclusively in the brain.  
 
RT-PCR analysis showed densin mRNA ex-
pression in glomeruli as well as in cultured hu-
man podocytes (Study V, Figure 2). cDNA 
prepared from rat brain tissue was used as a 
control. Sequencing of the amplified PCR prod-
ucts of brain and podocytes confirmed 100 % 
identity with densin. In Western blot analysis, 
the anti-densin antibody reacted with the anti-
gen of 210 kDa in human glomerular lysate, 
while a 185-kDa band was obtained from the 
lysate of cultured human podocytes (Study V, 
Figure 3A). Immunoblotting of human brain 
lysate revealed the corresponding 185-kDa band 
as expected based on previous studies by Izawa 
et al. (179). In addition to the interaction found 
for the rat, co-immunoprecipitation studies with 
the anti-nephrin antibody of human glomerular 
lysate confirmed this association of nephrin 
   
with densin in human, as well (Study V, Figure 
3 B). 
 
Immunofluorescence studies of semithin frozen 
sections using anti-densin antibody revealed 
intensive glomerular staining of podocytes 
(Study V, Figure 5A and B) and faint staining 
was also observed in proximal tubuli (Study V, 
Figure 5C). In immunoelectron microscopy 
(Study VI, Figure 6A, B and C), immunogold 
particles of anti-densin antibody were located to 
the slit diaphragm domains.  
Increased densin mRNA expression in CNF 
kidney cortex was detected by semiquantitative 
RT-PCR when compared to normal human cor-
tex (Study V, Figure 4A). Similarly, increased 
densin protein expression was revealed in CNF 
glomeruli by semiquantitative immunoblotting 
(Study V, Figure 4 B). However, in im-
munofluorescence studies, anti-densin antibod-
ies showed reduced staining in CNF glomeruli, 
while their staining intensity with anti-
podocalyxin antibodies remained unchanged 
between CNF and normal tissues (Study V, 
Table I).
 
   
Discussion 
 
1. Rat homologue of nephrin 
In order to establish the role of nephrin in well-
characterized rat animal models of proteinuria 
we cloned the rat nephrin sequence. High simi-
larity at the amino acid level as well as highly 
conserved domains suggested that the found rat 
cDNA was a homologue of the respective hu-
man nephrin cDNA. Later, other groups have 
cloned similar sequences of the rat (221, 222). 
All three separate amino acid sequences are al-
most identical apart from the signal sequence 
with the exception that sequence found in this 
study (accession number AF125521) includes 
asparagine at position 1218, whereas in the 
other 2 sequences it is aspartic acid. From the 
signal sequence we reported originally the first 
methionine 18 amino acids downstream from 
that in the other 2 sequences. However, in later 
studies (unpublished) we found the identical 
methionine and the first 17 amino acids also 
from our clone (Figure 4, AF125521). Interest-
ingly, Kawachi et al. (221) reported threonine at 
the second methionine position (Figure 4, 
AF161715). This could be explained as a se-
quencing artifact, but since other species (hu-
man and mouse) have the same amino acid in 
that position, it is most unlikely. Thus, there 
might be differentially expressed forms of 
nephrin that use different methionine codons for 
translation. 
 
 
 
 
 
HUMAN (AF035835)                                     MALGTTLRASLLLLGLLTEGLA 
 
RAT(AF125521)        MGAKRVTVRGARTSPIHRMSSLTPLLLMGMLTSGLA 
RAT(AF172255):       ------------------------------------------------------------------------ 
RAT(AF161715)       -------------------------------------T---------------------------------- 
 
MOUSE(AF172256):MGAKEVTVRGPGASPVHRTCRLIPLLLAGMLTTGLA 
MOUSE(AF168466):                                      MALGTTLRAS---------------------- 
 
 
Figure 4. Comparison of N-terminal signal sequences of nephrin according to different reports and 
species. The first methionine is bolded and the previously unpublished sequence is underlined. Se-
quences are numbered with the corresponding Genebank accession number. 
 
 
These changes are interesting also because of 
significant variation in two separately reported 
mouse sequences (222, 223) in that region. 
Holzman et al. (223) reported on the first me-
thionine of mouse in the same position as in the 
human sequence (Figure 4, AF168466) while 
Putaala et al. (222) reported on identical lengths 
of mouse and rat N-terminal signal sequences 
(Figure 4, AF172256). Holzman et al. (223) 
also suggested the first 10 amino acids of their 
clone to be identical to the human sequence, but 
Putaala et al. (222) reported on completely dif-
ferent amino acids in the corresponding region. 
2. Nephrin-specific mRNA is differen-
tially spliced  
In order to be translated into proteins, genes are 
first translated into non-functional pre-mRNA 
followed by splicing that removes introns and 
splices exons together producing final mRNA. 
However, as for alternative splicing, different 
exons can be included or excluded and thus 
several different mRNAs may be produced 
from a single gene with the ability to be trans-
lated into proteins. The picture is physiologi-
cally rather complicated since it has been esti-
mated that almost 60% of genes may have 
splice variants and, many of them, more than 
one (224, 225).  
 
In addition to the full-length nephrin we were 
able to isolate differentially transcribed clones 
from the rat glomeruli??The most interesting one 
and also the most abundant one after the whole-
length transcript is ??nephrin that lacks the 
transmembrane domain coded by exon 24, as 
well as for exons 25, 26 and 27 (numbering ac-
cording to the human NPHS1 (35). A transcript 
without exon 24 was obtained also from human 
indicating possible presence of soluble nephrin 
protein. Involvement of soluble nephrin in 
glomerular filtration is assumed since in the PA 
neprotic rats, nephrin-??mRNA showed similar 
down-regulation to the full-length transcript 
(226). In the same study, nephrin protein was 
detected from the proteinuric urine samples of 
the corresponding rat model. However, it re-
mains to be shown whether the detected nephrin 
in the urine represents the soluble form or 
whether it is released to the urine by some other 
mechanism like limited proteolysis. The impor-
tance of the soluble forms of transmembrane 
proteins has been found for example for the 
transmembrane-negative splice variant of vas-
cular endothelial cell growth factor receptor in-
hibiting the respective ligand activity (227). 
Similar functionally important isoforms lacking 
the transmembrane domain have been found, 
for instance for T-cell receptor (228) and the 
interleukin 6 receptor (229) as well as for the 
endothelial angiotensin converting enzyme 
(230).  
Recent studies have revealed an additional exon 
1A in the NPHS1 gene and different tissue ex-
pression patterns of nephrin-specific mRNA 
under different lengths of the NPHS1 promoter 
segment (56). This may implicate more com-
   
plex splicing combinations and thus involve-
ment of different isoforms of nephrin protein in 
different tissues and physiological conditions. 
3. Altered nephrin expression in ex-
perimental animal models 
The ethiology and pathogenesis of proteinuria 
are poorly understood. The molecular mecha-
nisms of the filtration function have been stud-
ied for years e.g. by using a variety of experi-
mental animal models. These rat models are 
well characterized and are in that sense still 
highly usable. Moreover, since the crucial im-
portance of glomerular filtration function for 
the whole body homeostasis, several filtration 
barrier gene-specific deficiencies of mice are 
lethal, and thus rat models are needed to pro-
vide samples from early and late stages of the 
disease. 
 
In studies regarding nephrin expression level, 
remarkable down-regulation of corresponding 
mRNAs and proteins was detected in PA 
nephrosis. A similar change has been reported 
e.g. in the acquired human nephrotic syndrome 
(231). This and particularly the finding that 
nephrin mRNA is reduced already before the 
onset of proteinuria indicate early nephrin 
involvement in the disease process. Its close 
association in the molecular mechanisms of 
disease is supported also by the obvious 
redistribution of nephrin between the apical 
plasma membrane and the SD in PA neprotic 
rats.  
Involvement of free oxygen radicals in nephrin 
regulation was studied by treating PA nephrotic 
animals with the antioxidant probucol. This 
treatment, however, failed to rescue normal 
nephrin mRNA expression. On the other hand, 
the dosage of probucol used alone appeared to 
slightly increase the level of nephrin mRNA. 
This may suggest certain degree of lipid peroxi-
dation in the appearance of nephrin expression 
in podocytes e.g. via effects on the intracellular 
signalling cascades. 
 
In Heymann nephritis, nephrin expression level 
remained unchanged. This might occur due to 
late sacrifice (12 weeks after the induction of 
disease) of the treated animals. At that time 
point, the possible damages may already have 
been missed as the long-term balance in the mo-
lecular complexes has obviously been reached. 
Thus, samples in this model should most proba-
bly be obtained at earlier time points to reflect 
the initiating primary events in the perturbation 
of the functional filtration barrier. 
4. Abnormal nephrin and densin ex-
pression in CNF kidneys 
Using PCR primers for flanking the transmem-
brane domain of nephrin, two reaction products 
could be observed both in normal and CNF 
glomeruli by RT-PCR. In immunofluorescent 
studies using anti-intra or anti-extracellular 
nephrin peptide antibodies, all but one CNF 
kidney failed to show reactivity (Study II). 
   
Moreover, nephrin immunoreactivity was de-
tected in EM analyses of some of the CNF sam-
ples studied, preferentially at the plasma mem-
branes. This result seems controversial since, 
particularly in Finmajor, no protein should be ex-
pressed (35). On the other hand, only homozy-
gosity in Finmajor mutations (early stop codon in 
exon 2) of NPHS1 should lead to complete loss 
of nephrin. The Finminor mutation found in 20% 
of Finnish patients causes a nonsense mutation 
at exon 26 beyond the recognition site of intra-
cellular antibodies used in IEM, and antibodies 
should normally also detect this product. Thus, 
the Finmajor/ Finminor may produce nephrin de-
tectable only in IEM analysis but not in indirect 
immunofluorescence microscopy. Also, in our 
semiquantitative RT-PCR studies (unpub-
lished), a 50-percent reduction in nephrin 
mRNA level was detected in CNF glomeruli, 
which may contribute to the reduced protein 
level as well. A CNF patient with glomerular 
reactivity in IF studies failed to show neither 
the Finmajor nor Finminor mutation in direct se-
quencing. Hence, this patient may present with 
other mutations in NPHS1 or in the respective 
promoter area.  
 
Most probably, critical mutations in some neph-
rin-associated proteins might also lead to dis-
turbed function of nephrin protein even if neph-
rin itself remained normally expressed. The im-
portance of the interactions found for nephrin is 
supported by the fact that in CNF glomeruli, 
densin mRNA and protein expression were in-
creased, evidenced by semiquantitative RT-
PCR and Western blotting when compared to 
normal glomeruli. However, the glomerular 
immunostaining for densin was reduced. This 
apparent controversy may reflect an abnormal 
distribution and localization of densin in the 
flattened podocytes due to the absence of SD 
and nephrin in CNF glomeruli preventing 
proper anchoring.  
5. Pancreatic nephrin expression  
In addition to kidney glomeruli, nephrin expres-
sion was detected in the islets of Langerhans, 
particularly in the insulin-producing ?-cells. In 
Western blot analysis, the affinity-purified 
nephrin antibody revealed two distinct bands 
from glomerulus with approximate MWs of 185 
and 165 kDa. However, in the pancreas, only 
the 165-kDa band was detected. This is most 
probably due to different glycosylation patterns 
of nephrin (30, 80). However, differently 
spliced forms of nephrin mRNA were observed 
in this thesis implicating the presence of differ-
ent protein forms of nephrin as well. Further-
more, Beltcheva et al.(56) reported on a novel 
exon upstream from the originally found exon 1 
in NPHS1. This exon is transcribed in a spe-
cific, tissue-dependent manner. Also, different 
promoter fragments have been shown to facili-
tate nephrin expression in different tissues (95). 
Thus, the lower migration band of pancreatic 
   
nephrin might depend on varying mRNA splic-
ing. 
 
Mutations in the NPHS1 gene cause dramatic 
changes in glomerular function as demonstrated 
in CNF (30). Beta-cell function in CNF pan-
creas has not been studied, and CNF patients do 
not show any symptoms of disturbed function 
of the pancreas. However, after kidney trans-
plantation, the patients undergo heavy immuno-
suppressive therapy, which has multiple meta-
bolic effects and thus can prevent outcome in 
the pancreas.  
 
Streptozotocin (STZ)-induced insulin-
dependent diabetes mellitus in the rat is an ani-
mal model of diabetes associated with proteinu-
ria (232, 233), and increased expression of the 
glomerular nephrin-specific mRNA (234). In 
light microscopy studies using anti-nephrin an-
tibodies, a less intense reactivity at the epithe-
lial region has been detected in STZ rats when 
compared to normal rat glomeruli. Furthermore, 
nephrin protein is lost to the urine in these rats 
(234). Whether the disease development in this 
model involves pancreatic nephrin remains to 
be investigated.  
Later in situ studies have shown high nephrin 
mRNA expression also in the hindbrain and in 
the developing spinal cord of mouse (222). 
LacZ-gene transgenic mice showed lacZ ex-
pression in the kidney, brain and pancreas under 
the NPHS1 gene promoter activity. Nephrin 
protein expression has also been verified in the 
mouse brain by immunohistochemical staining 
(109). In the studies by Liu et al. (235), nephrin 
mRNA and protein expression were detected in 
the mouse testis, particularly in the Sertoli cells. 
Moreover, our recent studies have revealed 
nephrin expression in selected cell types of the 
human lymphoid tissues (unpublished).  
 
In studies with transgenic mice it has been 
shown that different fragments of the nephrin 
promoter region are responsible for nephrin ex-
pression in different tissues. Interestingly, the 
omission of exon 1B of the mouse NPHS1 gene 
resulted in expression only in the kidney and 
brain whereas deletion of exon 1A launches a 
brain- and spinal cord-specific nephrin expres-
sion (56).  
6. Architecture of the slit diaphragm 
(SD) 
Electron microscopic results show that nephrin 
is clearly located at the filtration slit area and is 
in smaller amounts also present on the apical 
plasma membrane of podocytes. A similar lo-
calization pattern has been shown by other in-
vestigators as well (222, 223, 236). Also densin, 
a novel interaction partner of nephrin, obtained 
in co-immunoprecipitation studies with anti-
nephrin antibodies, localized particularly to the 
slit diaphragm domain. Thus, two additional 
members of the SD protein complex were found 
in this thesis (Figure 5).
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Schematic illustration of the molecular machinery in the slit diaphragm (SD). NEPH in-
dicates nephrin-like molecules NEPH-1, NEPH-2 and NEPH-3/filtrin. 
 
 
 We first proposed that the interaction of neph-
rin and densin may occur due to a larger protein 
complex. The proposal is supported by the fact 
that in the lysate, most of the membrane pro-
teins are still insoluble and larger membrane 
complexes remain in the supernatant allowing 
precipitation of proteins without direct interac-
tions. However, recent studies in our laboratory 
have revealed direct interaction between the 
intracellular regions of nephrin and densin pro-
teins (unpublished). This is interesting particu-
larly because of postulated functions of LAP 
proteins in the maintenance of apical-basal po-
larity in the cell (182). Thus, densin may direct 
other proteins, like nephrin, to localize at the 
SD. A similar function has also been proposed 
   
for another PDZ domain-containing protein in 
the SD, ZO-1 (Figure 5). 
 
The splice variant LRRC7 of densin shows 
ubiquitous mRNA expression profile in human 
organs, including the kidney (181). However, 
the putative size of the protein encoded by 
LRRC7 cDNA is only 25 kDa and the anti-
densin antibody and densin sequence specific 
primers used in this thesis are directed outside 
of LRRC7 coding region. Thus, the possible 
role of this splice variant in the kidney remains 
to be studied.  
 
The transmembranous nature of nephrin with an 
extracellular and a characteristic intracellular 
domain has shown to reflect functionality. The 
extracellular domain most likely mediates out-
side-in signalling (97). The intracellular part of 
nephrin mediates its binding to the cytoskeleton 
via CD2AP (81, 82) and directly to the mem-
brane proteins podocin and NEPH1 (57, 98). 
Since alpha-actinin-4 has been directly shown 
to interact with the densin PDZ domain (205), 
interaction of densin and nephrin may offer a 
novel link between the SD protein complex and 
the actin cytoskeleton. The intermediary role of 
alpha-actinin-4 appears important for the cy-
toarchitecture of podocytes (126) and mutations 
in the ACTN4 gene lead to familial focal seg-
mental glomerulosclerosis (FSGC) (132). Fur-
thermore, ACTN4-deficient mice develop severe 
abnormalities only in podocytes, demonstrating 
its importance in maintaining podocyte stability 
(134). 
 
The preferential association of nephrin to the 
SD and particularly to the detergent-resistant 
membrane domains, i.e. lipid rafts, and nephrin 
interactions with lipid raft proteins podocin and 
NEPH1 suggest that lipid rafts are crucial in the 
SD architecture (92, 97). However, in our stud-
ies densin failed to associate in the lipid rafts, 
but did instead in the high sucrose fractions af-
ter sucrose gradient centrifugation of glomeru-
lar lysate (data not shown). Interestingly, the 
main pool of nephrin was also localized in these 
high sucrose fractions (97). So far, SD proteins 
P-cadherin and FAT have not been reported to 
localize into lipid rafts. 
 
Hypothetical models of SD structure based on 
homophilic interactions between SD proteins of 
the adjacent secondary processes have been 
presented. Nephrin structure with its eight Ig-
like domains capable of homophilic interactions 
has been proposed to reflect its role as a back-
bone of the SD structure by connecting the ad-
jacent foot processes (237). The proposed func-
tion of densin in bridging presynaptic mem-
branes to postsynaptic ones in the glutamatergic 
synapses also remains intriguing: the physical 
dimensions match closely to the interpodocyte 
distance separated by the slit diaphragm. Homo-
typic adhesion found in some LRR-containing 
proteins also resembles the proposed functions 
   
of nephrin as an interpodocyte spacer. Simi-
larly, cadherin-like domains in the extracellular 
domain of FAT and P-cadherin (Figure 5) may 
theoretically mediate a homophilic connection 
across the slit pore. Moreover, it is most likely 
that the extracellular domains of SD proteins 
mediate also heterodimeric interactions as has 
already been shown for nephrin and NEPH1 
(98). RGD peptides in NEPH family members 
and in densin could mediate binding with in-
tegrins. Also, cysteine residues in densin and 
nephrin predict the presence of additional ex-
tracellular interactions.  
The intracellular region of CD2AP consists of 
SH3-like domains that are shown to bind typi-
cally to proline-rich regions of interacting pro-
teins. Interestingly, the intracellular domains of 
the NEPH family members, FAT and P-
cadherin, are abundant in proline and therefore 
this may indicate more interactions in the cyto-
solic part of the SD. Also, a typical function for 
the type I PDZ domains presented in densin and 
ZO-1 is to bind to distinct C-terminal sequences 
of other proteins (194). It is of particular inter-
est that the SD components FAT  and the NEPH 
family members contain the three typical C-
terminal amino acids (TEV) interacting with the 
PDZ I-type domains (194). Thus far, interac-
tions between the PDZ domain in ZO-1 and the 
TEV sequence in NEPH family members have 
been observed (120). Whether densin or ZO-1 
interact with FAT, or densin with NEPH family 
members, remain to be studied.   
   
   
Summary and future perspectives 
 
 
The kidney glomerulus maintains the crucially important filtration function (urine 
formation) by forming a barrier between the blood circulation and the tubular sys-
tem responsible for formation of the final urine. The filtration barrier consists of 
three separate layers: the fenestrated endothelium covering the inner aspect of 
capillaries, the glomerular basement membrane and, finally, the specialized 
epithelial cells, podocytes. The ability of podocytes to form long extensions called 
foot processes with unique intercellular structures called slit diaphragm (SD) re-
flects a special role in glomerular filtration.  
 
NPHS1 gene was detected in 1998 by positional cloning of the gene responsible 
for congenital nephrotic syndrome of the Finnish type (CNF). Earlier morphologi-
cal studies had shown an absence of the final sieve of glomerular filtration barrier, 
the slit diaphragms (SD), in CNF glomeruli. Thus, involvement of nephrin in po-
docyte derived filtration function was suspected. In this thesis nephrin was shown 
to localize to the SD region in podocytes. The rat homologue of nephrin was 
cloned and its involvement in an experimental rat model, PA nephrosis, was ob-
served. In addition to glomerular podocytes, nephrin expression was detected in 
pancreatic ?-cells and in the spleen. In the interaction studies of nephrin, the syn-
opse-specific protein densin was detected for the first time outside of the brain, in 
the podocytes. In addition to its interaction with nephrin, densin was also local-
ized to the SD domain in the podocytes.  
 
The composition of the protein complex forming the SD has been basically un-
known until the discovery of the NPHS1 gene. Nephrin localization to the SD fol-
lowed by detection of nephrin interacting proteins has brought new understanding 
of the pathophysiological mechanisms of glomerular filtration, especially the role 
of podocytes and SD in this barrier. It is expected that the information will lead to 
a deeper understanding of the disease mechanisms in the kidney glomeruli. New 
understanding is urgently needed since kidney diseases are not only difficult for 
the patients but are also enormously costly to treat. 
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